Biomerica (BMRA) Stock Statistics & Valuation Metrics

Biomerica has a market cap or net worth of $7.90M. The enterprise value is $6.48M.

Biomerica has 4,598,968 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biomerica’s return on equity (ROE) is -1.44 and return on invested capital (ROIC) is -106.12%.

The current PE Ratio of Biomerica is ―. Biomerica’s PEG ratio is 0.05.

In the last 12 months, Biomerica had revenue of 4.45M and earned -3.77M in profits. Earnings per share was -1.30.

In the last 12 months, operating cash flow was -3.42M and capital expenditures -37.00K, giving a free cash flow of -3.46M billion.

Biomerica pays an annual dividend of ―, resulting in a dividend yield of ―

Biomerica upcoming earnings date is Jan 8, 2027, TBA (Confirmed).

Biomerica as a current ratio of 1.62, with Debt / Equity ratio of ―

In the past 12 months, Biomerica has paid 23.00K in taxes.

Biomerica EV to EBITDA ratio is -1.62, with an EV/FCF ratio of -2.33.

Biomerica has $1.31M in cash and marketable securities with $2.33M in debt, giving a net cash position of -$575.00K billion.

Gross margin is ―, with operating margin of -119.47%, and net profit margin of -84.77%.

The average price target for Biomerica is ―, which is 11.43% higher than the current price. The consensus rating is ―